Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Human Health Holdings Ltd. (1419) Stock Price & Analysis

1 Followers

1419 Stock Chart & Stats

HK$0.79HK$0.03(3.29%)
At close: 4:00 PM GMT+8
HK$0.725HK$0.75HK$0.775HK$0.8Aug 17Aug 31Sep 15Sep 28Oct 14Oct 26Nov 9
Day’s Range
HKD 0.76 - HKD 0.79
52-Week Range
HKD 0.71 - HKD 0.87
Previous Close
HKD 0.76
Volume
N/A
Average Volume (3M)
28.13K
Market Cap
HKD 288.46M
Enterprise Value
-HKD 114.17M
Total Cash (Recent Filing)
HKD 523.53M
Total Debt (Recent Filing)
HKD 133.32M
Price to Earnings (P/E)
11.0
Beta
0.37
Next Earnings
Feb 19, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
Dec 11, 2026
Dividend Yield
3.82%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Very low leverage and stable equity provide financial resilience, reducing the strain of debt service during weaker operating periods. This capital structure should preserve flexibility to fund operations, maintain solvency, and support measured investment over the next several quarters.

Improving Cash Generation

The strong rebound in operating and free cash flow indicates that cash generation has recovered from the 2024 trough. Sustained positive free cash flow would improve self-funding capacity, support balance-sheet resilience, and give management more flexibility in capital allocation.

Recent Revenue Growth

Two consecutive years of meaningful revenue growth show that the business has regained commercial momentum after the 2024 decline. The relatively steady mid-40% gross margin also suggests the core offering retains economic value as sales expand.

Bears Say

Thin And Weakened Profitability

The sharp decline from earlier profitability peaks and the current ~4% net margin leave limited earnings cushion if costs rise or demand softens. Persistently thin margins can constrain reinvestment, reduce resilience, and make future earnings more dependent on revenue growth.

Uneven Cash Conversion

Although cash flow recovered, operating cash has not consistently matched reported profit, indicating uneven earnings quality. If this pattern persists, accounting profitability may translate less reliably into funds available for reinvestment, distributions, or balance-sheet strengthening.

Low Shareholder Returns

Low return on equity shows that the company is currently generating limited profit from its equity base despite conservative leverage. Unless profitability improves, weak capital efficiency could restrain long-term value creation and reduce the benefits of the otherwise solid balance sheet.

Human Health Holdings Ltd. News

1419 FAQ

What was Human Health Holdings Ltd.’s price range in the past 12 months?
Human Health Holdings Ltd. lowest stock price was HK$0.71 and its highest was HK$0.87 in the past 12 months.
What is Human Health Holdings Ltd.’s market cap?
Human Health Holdings Ltd.’s market cap is HK$288.46M.
When is Human Health Holdings Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Human Health Holdings Ltd.’s earnings last quarter?
Human Health Holdings Ltd. released its earnings results on Sep 29, 2026. The company reported HK$0.023 earnings per share for the quarter.
Is Human Health Holdings Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Human Health Holdings Ltd. pay dividends?
Human Health Holdings Ltd. pays an annual dividend of HK$0.031 which represents an annual dividend yield of 3.82%. See more information on Human Health Holdings Ltd. dividends here
What is Human Health Holdings Ltd.’s EPS estimate?
Human Health Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Human Health Holdings Ltd. have?
Human Health Holdings Ltd. has 379,552,220 shares outstanding.
What happened to Human Health Holdings Ltd.’s price movement after its last earnings report?
Human Health Holdings Ltd. reported an EPS of HK$0.023 in its last earnings report. Following the earnings report the stock price went down -3.896%.
Which hedge fund is a major shareholder of Human Health Holdings Ltd.?
Currently, no hedge funds are holding shares in HK:1419
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology